IL33 and cancer: Nuclear IL-33 mediates focal adhesion kinase (FAK)-dependent secretion of soluble ST2, a decoy receptor, and CCL5 from squamous cell carcinoma cells, which stimulates immunosuppressive Tregs leading to cancer immune evasion (194).